Industry Event: Clinical Trials in Rare Diseases Virtual (Dec 7-8, 2020) Webinar Topic: Rare Disease Studies – Data Challenges and Solutions Presented by: Andrew Schachter, Founder & CEO, Axiom Real-Time Metrics Kaitlyn Townsley, Associate Director of Product Innovation, Axiom Real-Time Metrics Topics covered: Critical use of eClinical solutions to manage Rare Disease studies in small-to-medium life science companies Oversight of …
VIDEO: DIA 2020 PharmaVOICE Editor’s Take: The Importance of a Unified Platform in Today’s Environment
Andrew Schachter, CEO and Founder, Axiom Real-Time Metrics Inc., outlines the importance of a unified platform to the success of clinical trials in today’s environment.
Data Ownership: Setting Up Your Study for Success
CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, is featured in PharmaVOICE’s June 2019 edition for feature article “Data Ownership: Setting Up Your Study for Success”. ARTICLE EXERPT: A small-to medium-size biotech or medical device company typically succeeds or fails on one pivotal study. It cannot be underestimated how important the study and operational data are to the success …
VIDEO: DIA 2017 PharmaVOICE Editor’s Take: “Unified” eClinical Suite
CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, speaks with PharmaVOICE at DIA 2017 on how small to mid-sized life sciences organizations select EDC vendors, the concept of “Unified” in an eClinical suite, the pain points for end-users, and the evolution of Axiom’s Fusion eClinical Suite.
Executive Viewpoints: The Evolving Impact of Patient-Centricity
CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, is featured in PharmaVOICE’s June 2017 edition’s “Executive Viewpoints” segment. ARTICLE EXCERPT: The Evolving Impact of Patient-Centricity The movement toward enabling the subject to be directly involved in various data streams such as diary and health-tracking information continues to evolve. For example, direct health activity data such as Fitbit information is …
Choosing the Right EDC/DM Partner: Critical Considerations for Small to Medium Sized Life Sciences Organizations
CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, is featured in PharmaVOICE’s June 2017 edition for feature article “Choosing the Right EDC/DM Partner: Critical Considerations for Small to Medium Sized Life Sciences Organizations”. ARTICLE EXCERPT: Whether you are a start-up pharmaceutical or biotech company, a medical devices innovator, or an established organization you want to be equipped with the …
Clinical Trials Yearbook: 5 Key Benefits to a Unified eClinical Suite
CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, is featured in the Clinical Trials Yearbook. ARTICLE EXCERPT: Keep calm and say no to the status quo: 5 Key Benefits to a Unified eClinical Suite Just as the iPad, Twitter and Smart Phones have changed how we communicate, access information, and generally move our knowledge forward, there are now enhanced …
Axiom Real-Time Metrics: Truly Unified eClinical Solutions
CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, is featured in Pharma Tech Outlook’s June 2016 edition cover story “Axiom Real-Time Metrics: Truly Unified eClinical Solutions”. ARTICLE EXERPT: Axiom is celebrating fifteen years as an innovative eClinical solutions and services provider. This milestone has been met through hard work, partnering with clients to meet their true needs, and operating …